← Leaderboards
Ryang Hwa Lee
Texas A&M University Health Science Ctr
$4,099,611
Attributed
$4,805,492
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,805,492 · 6
By mechanism
R01$3,618,137 · 3
R21$827,542 · 2
R56$359,813 · 1
Top collaborators
- Fei Liu4 shared
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- Fei Liu$5,080,918
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsTherapeutic EffectMesenchymal Stem CellsExtracellular VesiclesMediatingSafetyMouse ModelProteinsIn VitroPreventionSuccessImmuneAutoimmune DiseasesOverexpressionIn VivoInsightSide EffectS SyndromeInfusion ProceduresImmune ResponsePreventImmunoregulationPropertyEngineering
Grant awards (13)
Therapeutic mechanisms of iPSC-MSC derived extracellular vesicles on dry mouth caused by Sjorgren's syndrome or radiotherapy$643,574
R01 · FY2025 · DE
Engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of type 1 diabetes$572,947
R01 · FY2025 · DK · contact PI
Engineered extracellular vesicles derived from mesenchymal stem cells for the treatment of type 1 diabetes$567,641
R01 · FY2024 · DK · contact PI
Extracellular Vesicles derived from Mesenchymal Stem Cells as an Effective Medical Countermeasure against Mustard Induced Ocular Injury$228,750
R21 · FY2024 · EY · contact PI
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis$371,250
R01 · FY2023 · EY · contact PI
Extracellular Vesicles derived from Mesenchymal Stem Cells as an Effective Medical Countermeasure against Mustard Induced Ocular Injury$190,417
R21 · FY2023 · EY · contact PI
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis$360,113
R01 · FY2022 · EY · contact PI
Therapeutic mechanisms of iPSC-MSC derived extracellular vesicles on dry mouth caused by Sjorgren's syndrome or radiotherapy$359,813
R56 · FY2022 · DE
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis$360,112
R01 · FY2021 · EY · contact PI
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis$371,250
R01 · FY2020 · EY · contact PI
Extracellular Vesicles Produced by Mesenchymal Stem Cells as Novel Therapy for Autoimmune Uveitis$371,250
R01 · FY2019 · EY · contact PI
Therapeutic effects of MSC-derived extracellular vesicles on Sjögren's Syndrome$185,625
R21 · FY2019 · DE
Therapeutic effects of MSC-derived extracellular vesicles on Sjögren's Syndrome$222,750
R21 · FY2018 · DE